Trial intelligence / Profile preview

Propofol vs Ketofol for Hemodynamic Stability During ECT

NCT07273851Completed

Sponsor
Fauji Foundation Hospital
Start
Jul 2025
Primary completion
Dec 2025
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of ketofol in major depressive disorder (MDD) (2 arms), sponsored by Fauji Foundation Hospital. Primary endpoint: Mean Systolic Blood Pressure. Started Jul 2025; status: completed.

02

Drugs

ketofol
03

Conditions

major depressive disorder (MDD)

Beyond the preview

Go deeper on NCT07273851.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07273851.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call